Moreover, a specific genetic variation in the promoter of the IL-22 gene, which is associated with higher IL-22, Th1, Th22, and Th17 production in response to Mtb antigens, is more prevalent in control subjects compared to TB patients, suggesting a potential association with reduced susceptibility to TB [41,43]. The gene discussed is IL22; the disease is tuberculosis.